Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium "Care for CMMR-D" (C4CMMR-D)

被引:152
作者
Vasen, H. F. A. [1 ,2 ]
Ghorbanoghli, Z. [2 ]
Bourdeaut, F. [3 ]
Cabaret, O. [4 ]
Caron, O. [5 ]
Duval, A. [6 ]
Entz-Werle, N. [7 ]
Goldberg, Y. [8 ]
Ilencikova, D. [9 ]
Kratz, C. P. [10 ]
Lavoine, N. [11 ]
Loeffen, J. [12 ]
Menko, F. H. [13 ]
Muleris, M. [6 ]
Sebille, G. [14 ]
Colas, C. [15 ]
Burkhardt, B. [16 ]
Brugieres, L. [11 ]
Wimmer, K. [17 ]
机构
[1] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, NL-2333 AA Leiden, Netherlands
[2] Netherlands Fdn Detect Hereditary Tumours, Leiden, Netherlands
[3] Inst Curie, Dept Pediat Oncol, Paris, France
[4] Gustave Roussy Canc Inst, Dept Genet, Villejuif, France
[5] Gustave Roussy Canc Inst, Dept Oncogenet, Villejuif, France
[6] Saint Antoine Hosp, INSERM, Team Microsatellite Instabil & Canc, UMRS 938, Paris, France
[7] Univ Hosp, Dept Pediat Oncol, Strasbourg, France
[8] Hadassah Hebrew Med Ctr, Dept Oncol, Sharret Inst, Jerusalem, Israel
[9] Comenius Univ, Sch Med, Univ Childrens Hosp, Dept Pediat, Bratislava, Slovakia
[10] Hannover Med Sch, Dept Pediat Hematol & Oncol, Hannover, Germany
[11] Gustave Roussy Canc Inst, Dept Pediat, Villejuif, France
[12] Radboud Univ Nijmegen, Med Ctr, Dept Pediat Hematol & Oncol, Nijmegen, Netherlands
[13] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, Amsterdam, Netherlands
[14] Gustave Roussy Canc Inst, Dept Dermatol, Villejuif, France
[15] Hop La Pitie Salpetriere, APHP, Dept Genet, Paris, France
[16] Univ Hosp, Dept Pediat Hematol & Oncol, Munster, Germany
[17] Med Univ Innsbruck, Div Human Genet, A-6020 Innsbruck, Austria
关键词
CMMR-D; Constitutional mismatch repair deficiency; Surveillance; Guidelines; Tumour spectrum; BIALLELIC MSH6 MUTATIONS; COLORECTAL-CANCER CELLS; NON-HODGKIN-LYMPHOMA; LYNCH SYNDROME; COLON-CANCER; MICROSATELLITE-INSTABILITY; NEUROFIBROMATOSIS TYPE-1; CORPUS-CALLOSUM; GENE-MUTATIONS; RECTAL-CANCER;
D O I
10.1136/jmedgenet-2013-102238
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Lynch syndrome (LS) is an autosomal dominant disorder caused by a defect in one of the DNA mismatch repair genes: MLH1, MSH2, MSH6 and PMS2. In the last 15years, an increasing number of patients have been described with biallelic mismatch repair gene mutations causing a syndrome referred to as constitutional mismatch repair-deficiency' (CMMR-D). The spectrum of cancers observed in this syndrome differs from that found in LS, as about half develop brain tumours, around half develop digestive tract cancers and a third develop haematological malignancies. Brain tumours and haematological malignancies are mainly diagnosed in the first decade of life, and colorectal cancer (CRC) and small bowel cancer in the second and third decades of life. Surveillance for CRC in patients with LS is very effective. Therefore, an important question is whether surveillance for the most common CMMR-D-associated cancers will also be effective. Recently, a new European consortium was established with the aim of improving care for patients with CMMR-D. At a workshop of this group held in Paris in June 2013, one of the issues addressed was the development of surveillance guidelines. In 1968, criteria were proposed by WHO that should be met prior to the implementation of screening programmes. These criteria were used to assess surveillance in CMMR-D. The evaluation showed that surveillance for CRC is the only part of the programme that largely complies with the WHO criteria. The values of all other suggested screening protocols are unknown. In particular, it is questionable whether surveillance for haematological malignancies improves the already favourable outcome for patients with these tumours. Based on the available knowledge and the discussions at the workshop, the European consortium proposed a surveillance protocol. Prospective collection of all results of the surveillance is needed to evaluate the effectiveness of the programme.
引用
收藏
页码:283 / 293
页数:11
相关论文
共 65 条
  • [21] Surveillance for hereditary cancer: Does the benefit outweigh the psychological burden?-A systematic review
    Gopie, Jessica P.
    Vasen, Hans F. A.
    Tibben, Aad
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 83 (03) : 329 - 340
  • [22] Multifocal anaplastic astrocytoma in a patient with hereditary colorectal cancer, transcobalamin II deficiency, agenesis of the corpus callosum, mental retardation, and inherited PMS2 mutation
    Gururangan, Sridharan
    Frankel, Wendy
    Broadclus, Russell
    Clendenning, Mark
    Senter, Leigha
    McDonald, Marie
    Eastwood, James
    Reardon, David
    Vredenburgh, James
    Quinn, Jennifer
    Friedman, Henry S.
    [J]. NEURO-ONCOLOGY, 2008, 10 (01) : 93 - 97
  • [23] Haanstra JF, 2013, INT J COLORECTAL DIS
  • [24] Paediatric intestinal cancer and polyposis due to bi-allelic PMS2 mutations: Case series, review and follow-up guidelines
    Herkert, Johanna C.
    Niessen, Renee C.
    Olderode-Berends, Maria J. W.
    Veenstra-Knol, Hermine E.
    Vos, Yvonne J.
    van der Klift, Heleen M.
    Scheenstra, Rene
    Tops, Carli M. J.
    Karrenbeld, Arend
    Peters, Frans T. M.
    Hofstra, Robert M. W.
    Kleibeuker, Jan H.
    Sijmons, Rolf H.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 (07) : 965 - 982
  • [25] A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy
    Hunter, C
    Smith, R
    Cahill, DP
    Stephens, P
    Stevens, C
    Teague, J
    Greenman, C
    Edkins, S
    Bignell, G
    Davies, H
    O'Meara, S
    Parker, A
    Avis, T
    Barthorpe, S
    Brackenbury, L
    Buck, G
    Butler, A
    Clements, J
    Cole, J
    Dicks, E
    Forbes, S
    Gorton, M
    Gray, K
    Halliday, K
    Harrison, R
    Hills, K
    Hinton, J
    Jenkinson, A
    Jones, D
    Kosmidou, V
    Laman, R
    Lugg, R
    Menzies, A
    Perry, J
    Petty, R
    Raine, K
    Richardson, D
    Shepherd, R
    Small, A
    Solomon, H
    Tofts, C
    Varian, J
    West, S
    Widaa, S
    Yates, A
    Easton, DF
    Riggins, G
    Roy, JE
    Levine, KK
    Mueller, W
    [J]. CANCER RESEARCH, 2006, 66 (08) : 3987 - 3991
  • [26] High-Grade Brain Tumors in Siblings With Biallelic MSH6 Mutations
    Ilencikova, Denisa
    Sejnova, Daniela
    Jindrova, Jana
    Babal, Pavel
    [J]. PEDIATRIC BLOOD & CANCER, 2011, 57 (06) : 1067 - 1070
  • [27] Cafe-au-lait macules and pediatric malignancy caused by biallelic mutations in the DNA mismatch repair (MMR) gene PMS2
    Jackson, Carl-Christian
    Holter, Spring
    Pollett, Aaron
    Clendenning, Mark
    Chou, Shirley
    Senter, Leigha
    Ramphal, Raveena
    Gallinger, Steven
    Boycott, Kym
    [J]. PEDIATRIC BLOOD & CANCER, 2008, 50 (06) : 1268 - 1270
  • [28] Jacob S, 2001, CANCER RES, V61, P6555
  • [29] Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer
    Järvinen, HJ
    Aarnio, M
    Mustonen, H
    Aktan-Collan, K
    Aaltonen, LA
    Peltomäki, P
    de la Chapelle, A
    Mecklin, JP
    [J]. GASTROENTEROLOGY, 2000, 118 (05) : 829 - 834
  • [30] The multifaceted mismatch-repair system
    Jiricny, J
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2006, 7 (05) : 335 - 346